Stroke, Internal medicine, Surgery, Risk factor and Framingham Heart Study are his primary areas of study. Carlos S. Kase is interested in Intracerebral hemorrhage, which is a branch of Stroke. His research investigates the connection between Internal medicine and topics such as Cardiology that intersect with issues in Pathology.
Carlos S. Kase studied Surgery and Confidence interval that intersect with Myocardial infarction. The various areas that Carlos S. Kase examines in his Risk factor study include Diabetes mellitus, Relative risk and Physical therapy. His Framingham Heart Study research includes themes of Odds ratio, Incidence, Pediatrics and Cohort.
Carlos S. Kase mainly investigates Stroke, Internal medicine, Cardiology, Surgery and Intracerebral hemorrhage. His research integrates issues of Framingham Heart Study, Framingham Risk Score, Physical therapy, Cohort and Risk factor in his study of Stroke. His work deals with themes such as Dementia, Proportional hazards model and Incidence, which intersect with Framingham Heart Study.
Carlos S. Kase has researched Cardiology in several fields, including Diabetes mellitus, Hyperintensity and Pathology. His work carried out in the field of Surgery brings together such families of science as Cerebral infarction and Infarction. The study incorporates disciplines such as Hematoma, Radiology and Glasgow Coma Scale, Anesthesia in addition to Intracerebral hemorrhage.
The scientist’s investigation covers issues in Stroke, Internal medicine, Cardiology, Intracerebral hemorrhage and Surgery. His Stroke research is multidisciplinary, relying on both Framingham Risk Score, Epidemiology, Proportional hazards model, Physical therapy and Risk factor. His Cardiology research includes elements of Vascular endothelial growth factor, Baseline characteristics, Hyperintensity and Left ventricular hypertrophy.
His studies deal with areas such as Hematoma, Nuclear medicine, Computed tomography and Receiver operating characteristic as well as Intracerebral hemorrhage. His research in Surgery tackles topics such as Placebo which are related to areas like Fibrinolytic agent and Anesthesia. His Framingham Heart Study study which covers Cerebral amyloid angiopathy that intersects with Apolipoprotein E.
His primary areas of study are Stroke, Internal medicine, Framingham Heart Study, Cardiology and Physical therapy. His Stroke research incorporates elements of Framingham Risk Score, Randomized controlled trial, Surgery, Cohort study and Cohort. His Framingham Risk Score research is multidisciplinary, incorporating elements of Epidemiology and Physical medicine and rehabilitation.
His study in the fields of Prospective cohort study and Blood pressure under the domain of Internal medicine overlaps with other disciplines such as Offspring. His Framingham Heart Study research is multidisciplinary, incorporating perspectives in Hyperintensity, Incidence, Ischemic stroke, Dementia and Risk factor. In general Cardiology study, his work on Atrial fibrillation often relates to the realm of Growth factor, thereby connecting several areas of interest.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled Trial
Anthony Furlan;Randall Higashida;Lawrence Wechsler;Michael Gent.
An Updated Definition of Stroke for the 21st Century A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Ralph L. Sacco;Scott E. Kasner;Joseph P. Broderick;Louis R. Caplan.
Stroke Severity in Atrial Fibrillation The Framingham Study
Huey-Juan Lin;Philip A. Wolf;Margaret Kelly-Hayes;Alexa S. Beiser.
Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group.
Joseph Broderick;Sander Connolly;Edward Feldmann;Daniel Hanley.
Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke
Gregory J. Del Zoppo;Klaus Poeck;Michael S. Pessin;Samuel M. Wolpert.
Annals of Neurology (1992)
Plasma Concentration of C-Reactive Protein and Risk of Ischemic Stroke and Transient Ischemic Attack: The Framingham Study
Natalia S. Rost;Philip A. Wolf;Carlos S. Kase;Margaret Kelly-Hayes.
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association
Joseph P. Broderick;Harold P. Adams;William Barsan;William Feinberg.
The Lifetime Risk of Stroke Estimates From the Framingham Study
Sudha Seshadri;Alexa Beiser;Margaret Kelly-Hayes;Carlos S. Kase.
The influence of gender and age on disability following ischemic stroke: the Framingham study ☆
Margaret Kelly-Hayes;Alexa Beiser;Carlos S Kase;Amy Scaramucci.
Journal of Stroke & Cerebrovascular Diseases (2003)
Gender Differences in Stroke Incidence and Poststroke Disability in the Framingham Heart Study
Rodica E. Petrea;Alexa S. Beiser;Sudha Seshadri;Margaret Kelly-Hayes.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: